Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kearns

Showing results (31-40 of 382) with videos related to

Pageof 39
Sort By:
Clinical Pharmacokinetics|August 1, 1996
Pharmacokinetics and pharmacodynamics of famotidine in paediatric patientsL P James, G L Kearns
Clinical Pharmacology and Therapeutics|December 24, 2010
Histamine: new thoughts about a familiar mediatorB L Jones, G L Kearns
Clinical Pharmacology and Therapeutics|August 3, 1999
Developmental pharmacodynamics of cyclosporineJ D Marshall, G L Kearns
Progress in Neurobiology|March 30, 2000
Statistics of transmitter release at nerve terminalsM R Bennett, J L Kearns
Clinical Pharmacology and Therapeutics|October 31, 2003
American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedraAlan S Hollister, Gregory L Kearns
The Journal of the Arkansas Medical Society|September 1, 1984
Practical use of theophylline in children with asthmaT G Wells, G L Kearns
Texas Nursing|June 1, 1987
Getting involved in politicsM L Kearns, M L Armstrong
Pediatric Clinics of North America|October 1, 1989
Antimicrobial therapy for pediatric patientsR W Steele, G L Kearns
The Journal of Pediatrics|November 1, 1989
Cocaine: clinical pharmacology and toxicologyH C Farrar, G L Kearns
The Journal of the Arkansas Medical Society|February 1, 1985
Current perspectives in infantile apneaD H Fiser, G L Kearns
Pageof 39

Showing results (31-40 of 382) with videos related to

Sort By:
Pageof 39
Clinical Pharmacokinetics|August 1, 1996
Pharmacokinetics and pharmacodynamics of famotidine in paediatric patientsL P James, G L Kearns
Clinical Pharmacology and Therapeutics|December 24, 2010
Histamine: new thoughts about a familiar mediatorB L Jones, G L Kearns
Clinical Pharmacology and Therapeutics|August 3, 1999
Developmental pharmacodynamics of cyclosporineJ D Marshall, G L Kearns
Progress in Neurobiology|March 30, 2000
Statistics of transmitter release at nerve terminalsM R Bennett, J L Kearns
Clinical Pharmacology and Therapeutics|October 31, 2003
American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedraAlan S Hollister, Gregory L Kearns
The Journal of the Arkansas Medical Society|September 1, 1984
Practical use of theophylline in children with asthmaT G Wells, G L Kearns
Texas Nursing|June 1, 1987
Getting involved in politicsM L Kearns, M L Armstrong
Pediatric Clinics of North America|October 1, 1989
Antimicrobial therapy for pediatric patientsR W Steele, G L Kearns
The Journal of Pediatrics|November 1, 1989
Cocaine: clinical pharmacology and toxicologyH C Farrar, G L Kearns
The Journal of the Arkansas Medical Society|February 1, 1985
Current perspectives in infantile apneaD H Fiser, G L Kearns
Pageof 39